“Reducing saturated fat does not prevent heart attacks.”

• Cochrane's most recent systematic review of randomised trials (Hooper et al., 2020) found that reducing saturated fat produced little or no effect on all-cause mortality and cardiovascular mortality, and the effect estimates for myocardial infarction specifically were imprecise and not clearly significant — the clear benefit was for the broader composite of 'combined cardiovascular events.'
• Large meta-analyses of prospective cohort studies (Siri-Tarino et al., AJCN 2010; Chowdhury et al., Annals of Internal Medicine 2014) found no statistically significant association between habitual saturated fat intake and coronary heart disease risk, undercutting the simple 'less saturated fat = fewer heart attacks' model.
• Recovered data from two major randomised trials — the Minnesota Coronary Experiment (Ramsden et al., BMJ 2016) and the Sydney Diet Heart Study (Ramsden et al., BMJ 2013) — showed that replacing saturated fat with linoleic-acid-rich oils lowered serum cholesterol but did not reduce, and in some analyses increased, mortality.
• The Women's Health Initiative Dietary Modification Trial (Howard et al., JAMA 2006), the largest randomised dietary trial ever conducted (~48,800 women, ~8 years), found no statistically significant reduction in coronary heart disease or stroke from a low-fat diet that also reduced saturated fat.
• The PURE prospective study (Dehghan et al., Lancet 2017, 135,000+ people in 18 countries) reported that higher saturated fat intake was associated with lower total mortality and was not significantly associated with myocardial infarction or cardiovascular mortality.
• Cutting saturated fat alone, without specifying what replaces it, can be neutral or harmful: substituting refined carbohydrates or sugar for saturated fat shows no coronary benefit in pooled cohort analyses, so the blanket advice 'eat less saturated fat' is genuinely not reliably protective on its own.

• The same Cochrane review the claim leans on actually concluded that reducing saturated fat intake for at least two years causes a 'potentially important' ~17% reduction in combined cardiovascular events (RR ≈0.83), with greater benefit in trials achieving larger reductions in serum cholesterol — i.e., it does reduce cardiovascular events, the category that includes heart attacks.
• Meta-analysis of randomised controlled trials replacing saturated fat with polyunsaturated fat (Mozaffarian, Micha & Wallace, PLoS Medicine 2010) found a ~19% reduction in coronary heart disease events, with about 10% risk reduction per 5% of energy substituted.
• The American Heart Association's 2017 Presidential Advisory (Sacks et al., Circulation) reviewed the four best-controlled core trials (Oslo, LA Veterans, MRC, Finnish Mental Hospital) and found ~29% reduction in cardiovascular disease events when saturated fat was replaced with vegetable oil — comparable to statin effect sizes.
• Pooled prospective cohort analyses (Jakobsen et al., AJCN 2009; Li et al., JACC 2015) show that replacing saturated fat with polyunsaturated fat or whole grains is associated with significantly lower coronary event risk; the null cohort findings arise mainly because they ignore the replacement nutrient.
• Saturated fat consistently raises LDL cholesterol in controlled feeding studies, and Mendelian randomisation plus trial evidence (European Atherosclerosis Society Consensus, Ference et al., Eur Heart J 2017) establish LDL as causal for atherosclerotic events, providing a strong mechanistic chain from saturated fat reduction to fewer myocardial infarctions.
• WHO's 2023 guideline and essentially every major public health body (AHA, NHLBI, US/EU dietary guidelines) recommend limiting saturated fat to below ~10% of energy specifically to reduce cardiovascular disease risk, based on this body of evidence.
• The claim is stated as an unqualified absolute ('does not prevent'), which the evidence does not support; the honest summary is 'reducing saturated fat has not been clearly shown to reduce death rates, but does reduce cardiovascular events when replaced with polyunsaturated fat.'

78/100 — the lab’s own confidence in the score above, not a second reading of the claim.

Cochrane Database of Systematic Reviews (Hooper et al., 2020)journal · 96 · American Heart Association / Circulation (Sacks et al., 2017 Presidential Advisory)journal · 90 · PLoS Medicine (Mozaffarian, Micha & Wallace, 2010)journal · 88 · American Journal of Clinical Nutrition (Siri-Tarino et al., 2010)journal · 85 · Annals of Internal Medicine (Chowdhury et al., 2014)journal · 86 · The BMJ (Ramsden et al., 2016 — Minnesota Coronary Experiment)journal · 88 · The BMJ (Ramsden et al., 2013 — Sydney Diet Heart Study)journal · 85 · JAMA (Howard et al., 2006 — Women's Health Initiative Dietary Modification Trial)journal · 90 · The Lancet (Dehghan et al., 2017 — PURE study)journal · 84 · American Journal of Clinical Nutrition (Jakobsen et al., 2009)journal · 85 · European Heart Journal (Ference et al., 2017 — EAS Consensus on LDL causality)journal · 92 · World Health Organization — Saturated fatty acid and trans-fatty acid intake guideline (2023)gov · 90

• Randomized-trial evidence does not consistently show fewer myocardial infarctions specifically when saturated fat is reduced. The 2020 Cochrane review found little or no clear effect on nonfatal myocardial infarction, cardiovascular mortality, or all-cause mortality, even though it did find fewer combined cardiovascular events overall.
• Several observational meta-analyses have reported no statistically significant association between saturated-fat intake and coronary heart disease outcomes, which supports the narrower argument that simply eating less saturated fat has not reliably translated into fewer heart attacks in all evidence sets.
• The Women's Health Initiative low-fat diet trial reduced total fat and saturated fat modestly but did not significantly reduce coronary heart disease, myocardial infarction, or stroke over about 8 years; however, it was not a pure saturated-fat replacement trial.
• The Minnesota Coronary Experiment, a recovered randomized trial, lowered serum cholesterol by replacing saturated fat with linoleic-acid-rich vegetable oil but did not show a mortality benefit, illustrating that lowering saturated fat/cholesterol in a particular intervention did not necessarily prevent clinical events.

• The claim is too categorical: the best trial syntheses generally find that reducing saturated fat, especially when replaced with polyunsaturated fat rather than refined carbohydrate, reduces combined cardiovascular events. Some of those events include coronary events closely related to heart attacks.
• The American Heart Association's 2017 presidential advisory concluded that replacing saturated fat with polyunsaturated vegetable oils lowers cardiovascular disease incidence by about 30%, comparable to the effect of statin therapy in trials. That directly contradicts a blanket statement that saturated-fat reduction does not prevent heart attacks or related coronary events.
• Large cohort evidence from the Nurses' Health Study and Health Professionals Follow-up Study found that replacing saturated fat with polyunsaturated fat, monounsaturated fat, or whole-grain carbohydrates was associated with lower coronary heart disease risk, including nonfatal myocardial infarction and fatal CHD.
• Major public-health bodies, including WHO and the U.S. Dietary Guidelines, advise limiting saturated fat and replacing it with unsaturated fats because saturated fat raises LDL cholesterol, a causal risk factor for atherosclerotic cardiovascular disease. This supports prevention when the dietary replacement is appropriate.

84/100 — the lab’s own confidence in the score above, not a second reading of the claim.

Cochranejournal · 94 · American Heart Association / Circulationjournal · 91 · BMJjournal · 86 · BMJjournal · 84 · JAMAjournal · 88 · BMJjournal · 86 · World Health Organizationgov · 92 · U.S. Department of Agriculture / U.S. Department of Health and Human Servicesgov · 88

• Meta-analyses of prospective cohort studies, such as the widely cited 2010 Siri-Tarino study, have found no significant independent association between saturated fat intake and an increased risk of coronary heart disease (CHD) or cardiovascular disease (CVD).
• Nutritional science demonstrates that simply reducing saturated fat does not prevent heart attacks if the fat is replaced by refined carbohydrates or added sugars; doing so can actually worsen blood lipid profiles and increase cardiovascular risk.

• A 2017 Presidential Advisory from the American Heart Association (AHA) reviewed rigorous randomized controlled trials and concluded that lowering saturated fat and replacing it with polyunsaturated vegetable oil reduces the incidence of cardiovascular disease by approximately 30%, an effect size comparable to statin therapy.
• A comprehensive 2020 Cochrane Review of 15 randomized controlled trials involving over 59,000 participants found that reducing saturated fat intake for at least two years caused a statistically significant 21% reduction in combined cardiovascular events.
• Major global health authorities, including the World Health Organization (WHO) and the American College of Cardiology, continue to explicitly recommend limiting saturated fat to reduce the risk of ischemic heart disease and heart attacks.

95/100 — the lab’s own confidence in the score above, not a second reading of the claim.

American Heart Associationjournal · 95 · Cochrane Database of Systematic Reviewsjournal · 95 · American Journal of Clinical Nutritionjournal · 90

• The claim has limited support if interpreted narrowly: the 2020 Cochrane review found little or no effect of reducing saturated fat on nonfatal myocardial infarction (RR 0.97, 95% CI 0.87–1.07) and no clear reduction in coronary-heart-disease mortality; the evidence for heart attacks specifically was rated low or very low quality.[https://www.cochrane.org/evidence/CD011737_effect-cutting-down-saturated-fat-we-eat-our-risk-heart-disease]
• Reducing total fat without considering what replaces saturated fat may not help; Cochrane found no clear benefit when saturated fat was replaced with starchy foods, whereas benefits were more apparent when it was replaced with polyunsaturated fat.[https://www.cochrane.org/evidence/CD002137_cutting-down-or-changing-fat-we-eat-may-reduce-our-risk-heart-disease]
• The evidence does not show a clear reduction in mortality, so reducing saturated fat alone should not be portrayed as a guarantee against fatal heart attacks.[https://www.cochrane.org/evidence/CD011737_effect-cutting-down-saturated-fat-we-eat-our-risk-heart-disease]

• The claim is misleading as written because randomized-trial evidence summarized by Cochrane found that reducing saturated fat for at least two years reduced combined cardiovascular events by about 17% (RR 0.83, 95% CI 0.70–0.98), although the effect on myocardial infarction alone was uncertain.[https://www.cochrane.org/evidence/CD011737_effect-cutting-down-saturated-fat-we-eat-our-risk-heart-disease]
• An earlier Cochrane review found a 14% reduction in cardiovascular events from modifying dietary fat, particularly by replacing saturated fat with unsaturated fat, and concluded that this may reduce cardiovascular risk.[https://www.cochrane.org/evidence/CD002137_cutting-down-or-changing-fat-we-eat-may-reduce-our-risk-heart-disease]
• The American Heart Association reports that randomized controlled trials replacing saturated fat with polyunsaturated vegetable oil reduced cardiovascular disease by approximately 30%, and recommends limiting saturated fat as part of a heart-healthy dietary pattern.[https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000510]
• The AHA's scientific statement cites systematic-review evidence that saturated fat is more harmful for cardiovascular outcomes than unsaturated fat and recommends a low-saturated-fat dietary pattern.[https://www.ahajournals.org/doi/10.1161/cir.0000000000001031]

95/100 — the lab’s own confidence in the score above, not a second reading of the claim.

Cochranejournal · 98 · Cochranejournal · 98 · American Heart Associationjournal · 96 · American Heart Associationjournal · 96

• Re-analysis of the Minnesota Coronary Experiment (large RCT) found replacing saturated fat with linoleic acid lowered cholesterol but did not reduce coronary events or mortality and suggested possible harm with greater cholesterol drops.
• Meta-analyses of observational cohorts (Chowdhury 2014 in Annals of Internal Medicine; de Souza 2015) reported no significant association between saturated fat intake and coronary heart disease or cardiovascular events.
• The large PURE observational study (Lancet 2017) found saturated fat intake unassociated with myocardial infarction or CVD mortality and linked higher intake to lower stroke and total mortality.

• The 2020 Cochrane systematic review of RCTs found reducing saturated fat reduced combined cardiovascular events (including heart attacks) by 17%.
• The 2017 AHA Presidential Advisory concluded RCTs show replacing saturated fat with polyunsaturated fat reduces CVD events by about 30%.
• WHO, USDA Dietary Guidelines, and AHA continue to advise limiting saturated fat to lower heart-attack and CVD risk, citing LDL-C lowering plus trial data.

72/100 — the lab’s own confidence in the score above, not a second reading of the claim.

Cochranejournal · 95 · American Heart Association / Circulationjournal · 90 · The BMJjournal · 92 · The Lancetjournal · 93 · Annals of Internal Medicinejournal · 90